Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer

BackgroundSmall cell lung cancer (SCLC) is an aggressive malignancy characterized by initial chemosensitivity followed by resistance and rapid progression. Presently, there are no predictive biomarkers that can accurately guide the use of systemic therapy in SCLC patients. This study explores the ro...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Prantesh Jain, Mohammadhadi Khorrami, Amit Gupta, Prabhakar Rajiah, Kaustav Bera, Vidya Sankar Viswanathan, Pingfu Fu, Afshin Dowlati, Anant Madabhushi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2021-10-01
Saila:	Frontiers in Oncology
Gaiak:	radiomics computed tomography small cell lung cancer (SCLC) chemotherapy overall survival progression-free survival
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2021.744724/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!